Cibus, Inc.
NASDAQ:CBUS · NASDAQ Capital Market
-$0.02 today
Vol 0.11M · Avg 0.52M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $30.3M |
| Receivables | $1.8M |
| Other Current | $941.0K |
| Total Current Assets | $33.1M |
| PP&E (Net) | $26.6M |
| Goodwill | $232.5M |
| Intangible Assets | $31.2M |
| Other Non-current | $824.0K |
| Total Non-current Assets | $291.1M |
| Total Assets | $324.2M |
Analysis
Selected assets total $324.2M for Latest. The largest visible component is Goodwill at $232.5M, about 71.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.9M -31.2% | $14.4M -55.9% | $32.7M +854.2% | $3.4M -75.2% | $13.8M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $703.0K -32.5% | $1.0M +96.4% | $530.0K | $0 | $0 | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $1.4M -2.0% | $1.5M -26.1% | $2.0M +182.4% | $705.0K +41.3% | $499.0K | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $12.1M -28.8% | $16.9M -51.9% | $35.2M +752.4% | $4.1M -72.8% | $15.2M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $27.9M -37.7% | $44.7M +19.3% | $37.5M +106.6% | $18.1M -16.6% | $21.7M | $1.2B | $1.5B | $687.8M |
| Goodwill | $232.5M -8.3% | $253.5M -41.7% | $434.9M | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $31.7M -5.7% | $33.6M -5.2% | $35.4M +22312.0% | $158.0K | $0 | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $926.0K -33.2% | $1.4M -2.5% | $1.4M | $0 -100.0% | $282.0K | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $293.0M -12.1% | $333.1M -34.6% | $509.2M +2684.1% | $18.3M -16.9% | $22.0M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $305.0M -12.9% | $350.1M -35.7% | $544.4M +2328.1% | $22.4M -39.7% | $37.2M | $13.3B | $11.9B | $10.6B |
| Account Payables | $8.1M +35.3% | $6.0M -2.7% | $6.1M +1702.1% | $340.0K -73.0% | $1.3M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $3.2M +626.1% | $436.0K -47.7% | $833.0K | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $536.0K -42.5% | $932.0K -23.0% | $1.2M +1030.8% | $107.0K | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $5.1M -13.3% | $5.9M +10.8% | $5.3M +1213.2% | $403.0K -85.1% | $2.7M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $16.9M -15.2% | $19.9M -6.8% | $21.3M +1183.0% | $1.7M -65.8% | $4.9M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $235.0M +103889.4% | $226.0K -57.8% | $536.0K | $0 | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $1.6M -99.2% | $200.9M +20.2% | $167.1M +211444.3% | $79.0K -88.7% | $702.0K | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $266.4M +14.6% | $232.4M +25.7% | $184.8M +1266.2% | $13.5M -25.7% | $18.2M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $283.2M +12.3% | $252.2M +22.4% | $206.1M +1257.1% | $15.2M -34.1% | $23.1M | $14.7B | $3.7B | $9.6B |
| Common Stock | $79.0K +777.8% | $9.0K +12.5% | $8.0K +60.0% | $5.0K +25.0% | $4.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$858.3M -17.4% | -$731.2M -52.4% | -$479.8M -126.1% | -$212.2M -8.2% | -$196.1M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $39.0K +160.0% | $15.0K +87.5% | $8.0K | $0 | $0 | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 -100.0% | $5.7M -87.3% | $44.8M | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $21.8M -77.7% | $97.8M -71.1% | $338.3M +4577.1% | $7.2M -48.8% | $14.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $268.0M +638.5% | $36.3M +47.4% | $24.6M +77.0% | $13.9M -22.2% | $17.9M | $724.2M | $410.6M | $399.4M |
| Net Debt | $258.0M +1080.8% | $21.9M +370.5% | -$8.1M -177.1% | $10.5M +158.7% | $4.1M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Relmada Therapeutics, Inc.
NASDAQ:RLMD
$487.67M
Unicycive Therapeutics, Inc.
NASDAQ:UNCY
$155.81M
Immunic, Inc.
NASDAQ:IMUX
$136.78M
Vaxart, Inc.
NASDAQ:VXRT
$135.55M
Repare Therapeutics Inc.
RPTX
$114.24M
CAMP4 Therapeutics Corporation
NASDAQ:CAMP
$89.00M
Biomea Fusion, Inc.
NASDAQ:BMEA
$69.61M
MediciNova, Inc.
NASDAQ:MNOV
$60.54M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$59.20M
Acrivon Therapeutics, Inc. Common Stock
ACRV
$46.70M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does CBUS have?
Cibus, Inc. (CBUS) reported $9.92M in cash and equivalents in fiscal 2025.
How much debt does CBUS carry?
Cibus, Inc. (CBUS) reported $267.96M of total debt, with net debt of $258.04M.
Explore More
Continue the stock analysis
Jump to another research area for this company.